Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...
We independently review everything we recommend. We may get paid to link out to retailer sites, and when you buy through our links, we may earn a commission. Learn more› By Adrienne Maxwell Adrienne ...
The May U.S occupancy rate fell again year over year, according to hotel analytics firm STR, while average daily rate and revenue per available room each increased slightly. U.S. occupancy in May ...
WAILUKU, Hawaii (KHON2) — The Maui County Council will have a public hearing on June 9 to discuss whether to phase out thousands of vacation rentals on the island. Mayor Richard Bissen introduced Bill ...
Molecules like DNA are capable of storing large amounts of data without requiring an energy source, but accessing this molecular data is expensive and time consuming. Publishing May 16 in the Cell ...
Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program. The asset in question, dubbed ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today ...
** When you buy products through the links on our site, we may earn a commission that supports NRA's mission to protect, preserve and defend the Second Amendment. ** Photos courtesy of ...
A landmark study has begun to unravel one of the fundamental mysteries in neuroscience -- how the human brain encodes and makes sense of the flow of time and experiences. A landmark study led by UCLA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback